Partner with HC21
Your route to market
We work with international medtech manufacturers to successfully commercialise products across the UK and Ireland, combining deep local market understanding with proven sales and marketing expertise.
Our model is designed to reduce complexity, protect existing business and support sustainable growth within two of the most established and regulated healthcare markets.
What our partners say
What to expect
Improving commercial and operational outcomes
Portfolio lifecycle management
Supporting the longevity and relevance of medtech portfolios, including mature and high revenue product ranges.
Transparency
By managing established portfolios, we enable partners to focus internal resources on innovation, launches and strategic growth products.
Supply chain rationalisation
Consolidated ordering and invoicing can simplify operations and reduce supply chain workload, providing a more efficient route to market.
Predictable revenue and margin
Consistent ordering and dependable revenue streams supporting long term commercial planning.
Our experience includes:
Connected through AddLife
Trusted by our partners
Built for the long term
Whether you’re entering the UK and Ireland, optimising an existing route to market, or transitioning an established portfolio, we can support you with the expertise, infrastructure and teams to make it work.







